The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Gilead Sciences to Present at Two Upcoming Investor Conferences

<p class='bwalignc'> <i><b>- 14</b></i><sup><i><b>th</b></i></sup><i><b> Annual BIO CEO & Investor Conference on February 14</b></i><sup><i><b>th</b></i></sup><i><b> -</b></i> </p> <p class='bwalignc'> <i><b>- Leerink Swan Global Healthcare Conference 2012 on February 15</b></i><sup><i><b>th</b></i></sup><i><b> -</b></i> </p> <p class='bwalignc'> <i><b>- Webcasts Available Through Gilead Corporate Website -</b></i> </p>

Thursday, February 09, 2012

Gilead Sciences to Present at Two Upcoming Investor Conferences16:30 EST Thursday, February 09, 2012 FOSTER CITY, Calif. (Business Wire) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F. Milligan, PhD, Gilead's President and Chief Operating Officer, will be participating in “fireside chat” forums at two upcoming investor conferences taking place in New York. The first will take place at the BIO CEO & Investor Conference, available via a replay on Gilead's website after 4:00 p.m. Eastern Time (ET), on Tuesday, February 14. The second will occur at the Leerink Swan Global Healthcare Conference 2012 on Wednesday, February 15 at 11:00 a.m. ET, available via webcast. To access the webcasts or a replay via the Internet, log on to www.gilead.com. For the Leerink Swan presentation, please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replays will be available for 14 days following the presentations. About Gilead Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Asia Pacific. For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235). Gilead Sciences, Inc.Susan Hubbard, 650-522-5715 (Investor Relations)